Institutional Repository of Vilnius University
Priešfibroziniu vaistu pakrauto polimerinio nešiklio panaudojimo tyrimas in vitro /
Abstract
dc:descriptionVarious fibrotic diseases are one of the leading causes of mortality in developed countries. The main tissue effector in these diseases is the myofibroblast cell. During fibrosis myofibroblasts proliferate intensily and produce large quantities of extracellular matrix which inhibits the efective functioning of the afflicted tissues. Current treatments are still not advanced to the point of being able fully cure fibrotic diseases, they can only inhibit their progression. Furthermore the medication that is currently in use causes various side effects to the users. With that in mind the goal of the research codescribed in this paper is to create a drug carrier which would localize the realease of the antifibrotic medication allowing the reduction of side effect and also a controlled release time of the drug. Multiple different polylactic acid and polycaprolactone copolymers were examined by doing antifibrotic drug release experiments and the copolymer with the best ratio (90:10) of the two polymers was chosen. This copolymers structure was then modified using electrospinning, creating a copolymer-drug net. Afterwards in vitro experiments with human myofibroblasts (WPMY and HMF cell lines) were conducted to test biocompatabily and how effective the construct is. The rezults showed that the netted structure had only a minimal toxic affect to cells on the first day of exposure and after 7 days this effect was no longer seen. Measurements of changes in the expression of genes associated with fibrosis (TGFB1, TIMP1, PAI1, CTGF, VEGFA and MMP1) showed that when the drug is delivered directly to the myofibroblasts after 7 days there is a statistically significant increase in the expression of profibrotic genes VEGFA, CTGF and TIMP1. Meanwhile in the group affected by the drug being delivered through the copolymer carrier these negative effects were not seen. To summarize in vitro experiments showed that the antifibrotic drugs delivery through the created copolymer carrier could potentially be a safe and effective method of fibrosis treatment.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Buivydas, Andrius,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD192981930&prefLang=en_US